Notificação de entrada na fase nacional - PCT
#1.3
03/24/2026
RPI 2881
Application data
Number
112025011174Type
Filing
Publication
PCT
CN2023137517 Examination has not been requested yet. Without that request by 12/08/2026, the application is definitively abandoned (art. 33 of the Brazilian IP Act).
Deadline to request examination:12/08/2026(105 days left)
Latest action published by the INPI: 03/24/2026. We update with every new RPI gazette, published weekly.
Applicants
LANOVA MEDICINES LIMITED
CN
Inventors
H. G. (pessoa física)
CN
R. L. (pessoa física)
CN
W. C. (pessoa física)
CN
W. H. (pessoa física)
CN
Y. Z. (pessoa física)
CN
IPC Classification
Priority claims
CN
PCT/CN2022/138363 · 12/12/2022
Abstract
ANTICORPOS BIESPECÍFICOS QUE ALVEJAM PD1 E VEGF. São fornecidos anticorpos biespecíficos capazes de se ligarem à proteína de VEGF humano e à proteína de PD-1 humana. Esses anticorpos biespecíficos são eficazes no tratamento de câncer.
Publications in the Brazilian Industrial Property Gazette (RPI).
#1.3
03/24/2026
RPI 2881
#1.1
06/10/2025
RPI 2840
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.